Please ensure Javascript is enabled for purposes of website accessibility

Supernus Pharmaceutucals asks FDA to approve new ADHD drug (access required)

A Rockville drug company working on treatments for central nervous system diseases has asked the Food and Drug Administration to approve the sale and marketing of a new drug to treat attention deficit hyperactivity disorder.

To purchase a reprint of this article, contact [email protected].